HomeXERS • NASDAQ
add
Xeris Biopharma Holdings Inc
Previous close
$4.79
Day range
$4.80 - $5.00
Year range
$1.86 - $6.07
Market cap
781.56M USD
Avg Volume
2.61M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 60.12M | 47.94% |
Operating expense | 54.48M | 11.39% |
Net income | -9.22M | 51.42% |
Net profit margin | -15.34 | 67.15% |
Earnings per share | -0.06 | 57.14% |
EBITDA | -65.00K | 99.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 58.44M | -33.10% |
Total assets | 315.45M | -6.29% |
Total liabilities | 350.58M | 1.38% |
Total equity | -35.13M | — |
Shares outstanding | 160.16M | — |
Price to book | -20.83 | — |
Return on assets | -2.42% | — |
Return on capital | -3.25% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -9.22M | 51.42% |
Cash from operations | -10.03M | 50.59% |
Cash from investing | -13.00K | 99.93% |
Cash from financing | -3.14M | -108.91% |
Net change in cash | -13.18M | -176.97% |
Free cash flow | -9.36M | 70.07% |
About
Founded
2005
Headquarters
Website
Employees
394
